Back to User profile » Dr Osamu Hataji
Papers published by Dr Osamu Hataji:
Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study
Yatera K, Wang Z, Shibata Y, Ishikawa N, Homma T, Fukushima K, Hataji O, Inoue Y, Kawabata H, Miki K, Sato K, Tobino K, Yoshida M, Ishii T, Ito R, Kobayashi T, Kawamatsu S, Compton CH, Jones PW
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:1477-1492
Published Date: 14 May 2025
A Telemedicine Approach for Monitoring COPD: A Prospective Feasibility and Acceptability Cohort Study
Shinoda M, Hataji O, Miura M, Kinoshita M, Mizoo A, Tobino K, Soutome T, Nishi T, Ishii T, Miller BE, Tal-Singer R, Tomlinson R, Matsuki T, Jones PW, Shibata Y
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2931-2944
Published Date: 17 November 2022
The Potential of Digital Polymerase Chain Reaction for Improving Diagnostic Yield of Nontuberculous Mycobacteria Pulmonary Disease
Nishii Y, Furuhashi K, Nakamura S, Nishio M, Nakamura Y, Ushiro K, Ito K, Sakaguchi T, Suzuki Y, Fujiwara K, Yasuma T, Kobayashi T, D'Alessandro-Gabazza C, Gabazza EC, Taguchi O, Hataji O
Infection and Drug Resistance 2021, 14:5079-5087
Published Date: 1 December 2021
Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD
Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2993-3002
Published Date: 23 December 2019
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study
Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2979-2991
Published Date: 23 December 2019
Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease
Hataji O, Naito M, Ito K, Watanabe F, Gabazza EC, Taguchi O
International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:1-5
Published Date: 28 December 2012